The CEO of this company appointed earlier in the year is making major changes and pushing key programs and milestones ahead.Market sentiment in this sector has also played a major role in the decimation of the sp. Earlier in the year the sp traded over 20 cents based mainly on sentiment in the sector. Cannabis was a $ 20 billion industry last year which has increased to $ 26 billion this year so it is definitely no fad and only getting stronger . It should also be noted that the CEO is one of the largest shareholders so you would think increasing value is a major priority.
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann to Commence Cannabinoid Trial in Spinal Cord Injury
Ann: AusCann to Commence Cannabinoid Trial in Spinal Cord Injury, page-6
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online